Infarct Size After Acute Myocardial Infarction Measured by Quantitative Tomographic 99m Tc Sestamibi Imaging Predicts Subsequent Mortality
- 1 August 1995
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 92 (3) , 334-341
- https://doi.org/10.1161/01.cir.92.3.334
Abstract
Background 99m Tc sestamibi is a recently developed radioisotope that has been used to measure myocardium at risk and infarct size. The relation between these measurements and subsequent patient outcome has not yet been demonstrated. Methods and Results Two hundred seventy-four consecutive patients with acute myocardial infarction underwent tomographic 99m Tc sestamibi imaging on arrival at the hospital (to measure myocardium at risk before reperfusion therapy) and at hospital discharge (to measure the amount of salvaged myocardium and final infarct size). Defect size on the sestamibi images was quantified using a threshold value of 60% of peak counts from the circumferential count profile curves generated for five representative slices of the left ventricle. Patients were followed after hospital discharge to evaluate the association between final infarct size and subsequent mortality. The median defect size measured was 27% of the left ventricle at presentation to the hospital (range, 0% to 77%) and was 12% of the left ventricle at hospital discharge (range, 0% to 68%). Almost one half of the patients had a final infarct size of ≤10%. The median amount of myocardium salvaged was 9% (range, −31% to 75%). During a median duration of follow-up of 12 months, there were 10 deaths (7 cardiac and 3 noncardiac) and 1 resuscitated out-of-hospital cardiac arrest. There was a significant association between infarct size and overall mortality (χ 2 =8.66, P =.003) and cardiac mortality (χ 2 =11.89, P <.001). Two-year mortality was 7% for patients whose infarct size was ≥12% versus 0% for patients whose infarct size was 2 =6.87, P =.009). There was no association between myocardium at risk and overall mortality or between amount of myocardium salvaged and either overall mortality or cardiac mortality. Conclusions Larger infarct size measured by 99m Tc sestamibi imaging after acute myocardial infarction is associated with increased mortality risk during short-term follow-up.Keywords
This publication has 45 references indexed in Scilit:
- Comparison of reinjection thallium 201 and resting technetium 99m sestamibi tomographic images for the quantification of infarct size after acute myocardial infarctionJournal of Nuclear Cardiology, 1994
- Relation of left ventricular volume and function over one year after acute myocardial infarction to infarct size determined by technetium-99m sestamibiThe American Journal of Cardiology, 1991
- Comparison of Invasive and Conservative Strategies after Treatment with Intravenous Tissue Plasminogen Activator in Acute Myocardial InfarctionNew England Journal of Medicine, 1989
- Peak creatine kinase as a measure of effectiveness of thrombolytic therapy in acute myocardial infarctionThe American Journal of Cardiology, 1987
- Beta blockade during and after myocardial infarction: An overview of the randomized trialsProgress in Cardiovascular Diseases, 1985
- Risk Stratification and Survival after Myocardial InfarctionNew England Journal of Medicine, 1983
- Late prognostic value of scintigraphic parameters of acute myocardial infarction size in complicated myocardial infarction without heart failureThe American Journal of Cardiology, 1983
- Prognostic Value of Exercise Testing Soon after Myocardial InfarctionNew England Journal of Medicine, 1979
- Hemodynamic Spectrum of Myocardial Infarction and Cardiogenic ShockCirculation, 1972
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958